Salgado Diamantino Ribeiro, Verdeal Juan Carlos Rosso, Rocco José Rodolfo
Intensive Care Unit, Barra Dor Hospital, Avenida Ayrton Senna 2541, Barra da Tijuca, Rio de Janeiro CEP 22775-001, Brazil.
Crit Care. 2006;10(5):R149. doi: 10.1186/cc5077.
Adrenal failure (AF) is associated with increased mortality in septic patients. Nonetheless, there is no agreement regarding the best diagnostic criteria for AF. We compared the diagnosis of AF considering different baseline total cortisol cutoff values and Deltamax values after low (1 microg) and high (249 microg) doses of corticotropin, we analyzed the impact of serum albumin on AF identification and we correlated laboratorial AF with norepinephrine removal.
A prospective noninterventional study was performed in an intensive care unit from May 2002 to May 2005, including septic shock patients over 18 years old without previous steroid usage. After measurement of serum albumin and baseline total cortisol, the patients were sequentially submitted to 1 microg and 249 microg corticotropin tests with a 60-minute interval between doses. Post-stimuli cortisol levels were drawn 60 minutes after each test (cortisol 60 and cortisol 120). The cortisol 60 and cortisol 120 values minus baseline were called Deltamax1 and Deltamax249, respectively. Adrenal failure was defined as Deltamax249 < or = 9 microg/dl or baseline cortisol < or = 10 microg/dl. Other baseline cortisol cutoff values referred to as AF in other studies (< or =15, < or =20, < or =25 and < or =34 mug/dl) were compared with Deltamax249 < or = 9 microg/dl and serum albumin influence. Norepinephrine removal was compared with the baseline cortisol values and Deltamax249 values.
We enrolled 102 patients (43 male). AF was diagnosed in 22.5% (23/102). Patients with albumin < or =2.5 g/dl presented a lower baseline total cortisol level (15.5 microg/dl vs 22.4 microg/dl, P = 0.04) and a higher frequency of baseline cortisol < or =25 microg/dl (84% vs 58.3%, P = 0.05) than those with albumin > 2.5 g/dl. The Deltamax249 levels and Deltamax249 < or = 9, however, were not affected by serum albumin (14.5 microg/dl vs 18.8 microg/dl, P = 0.48 and 24% vs 25%, P = 1.0). Baseline cortisol < or = 23.6 microg/dl was the most accurate diagnostic threshold to determine norepinephrine removal according to the receiver operating characteristic curve.
AF was identified in 22.5% of the studied population. Since Deltamax249 < or = 9 microg/dl results were not affected by serum albumin and since the baseline serum total cortisol varied directly with albumin levels, we propose that Deltamax249 < or = 9 microg/dl, which means Deltamax after high corticotropin dose may be a better option for AF diagnosis whenever measurement of free cortisol is not available. Baseline cortisol < or =23.6 microg/dl was the best value for predicting norepinephrine removal in patients without corticosteroid treatment.
肾上腺功能衰竭(AF)与脓毒症患者死亡率增加相关。然而,关于AF的最佳诊断标准尚无共识。我们比较了在低剂量(1微克)和高剂量(249微克)促肾上腺皮质激素后,考虑不同基线总皮质醇临界值和Deltamax值时AF的诊断情况,分析了血清白蛋白对AF识别的影响,并将实验室诊断的AF与去甲肾上腺素清除情况进行了关联。
2002年5月至2005年5月在一家重症监护病房进行了一项前瞻性非干预性研究,纳入年龄超过18岁、既往未使用过类固醇的脓毒症休克患者。在测量血清白蛋白和基线总皮质醇后,患者依次接受1微克和249微克促肾上腺皮质激素试验,两次剂量之间间隔60分钟。每次试验后60分钟采集刺激后皮质醇水平(皮质醇60和皮质醇120)。皮质醇60和皮质醇120值减去基线值分别称为Deltamax1和Deltamax249。肾上腺功能衰竭定义为Deltamax249≤9微克/分升或基线皮质醇≤10微克/分升。将其他研究中称为AF的其他基线皮质醇临界值(≤15、≤20、≤25和≤34微克/分升)与Deltamax249≤9微克/分升及血清白蛋白的影响进行比较。将去甲肾上腺素清除情况与基线皮质醇值和Deltamax249值进行比较。
我们纳入了102例患者(43例男性)。22.5%(23/102)的患者被诊断为AF。白蛋白≤2.5克/分升的患者与白蛋白>2.5克/分升的患者相比,基线总皮质醇水平较低(15.5微克/分升对22.4微克/分升,P = 0.04),基线皮质醇≤25微克/分升的频率较高(84%对58.3%,P = 0.05)。然而,Deltamax249水平及Deltamax249≤9不受血清白蛋白影响(14.5微克/分升对18.8微克/分升,P = 0.48;24%对25%,P = 1.0)。根据受试者工作特征曲线,基线皮质醇≤23.6微克/分升是确定去甲肾上腺素清除情况的最准确诊断阈值。
在所研究人群中,22.5%的患者被诊断为AF。由于Deltamax249≤9微克/分升的结果不受血清白蛋白影响,且基线血清总皮质醇与白蛋白水平直接相关,我们建议,当无法测量游离皮质醇时,Deltamax249≤9微克/分升,即高剂量促肾上腺皮质激素后的Deltamax,可能是AF诊断的更好选择。基线皮质醇≤23.6微克/分升是预测未接受皮质类固醇治疗患者去甲肾上腺素清除情况的最佳值。